To elucidate the distribution and nature of EGF in human body fluids, we measured immunoreactive EGF (IR-EGF) by a RIA or a (more sensitive) time-resolved immunofluorometric assay, and evaluated its size heterogeneity by size exclusion high performance liquid chromatography. The mean concentration was 80nglml in urine, 65nglml in milk, 50ngIml in seminal plasma, 25ng/ml in armpit sweat, 1.0 nglml in breast sweat, 3ngIml in saliva, 1.5ngl ml in tears, and 0.3nglml in gastric juice and third trimester amniotic fluid. All the fluids contained the standard size 6.2 kilodalton (6.2K) IR-EGF molecule. It was the only component present in armpit sweat and gastric juice. Additionally, we observed the total of 5 different molecular sizes of IR-EGF, ranging in approximate molecular weight from 400K to 15K. The standard form made up '90% of the total IR-EGF in all the fluids except the amniotic fluid, where its proportion was 71%. A >400K component was present in milk and amniotic fluid, a 300K component in urine and seminal plasma, a 200K component in breast sweat, a 80K component in seminal plasma, saliva and tears and a 15K component in urine, seminal plasma, and the amniotic fluid. It remains to be studied whether the larger than standard forms 38 F . P e i l l o n x , c .~i a p i~, P -G a r n i e r , A .M.BrandiX, D.Evain B r i o n , D . B r e s s i o n X , H . S c h e r r e r x , M .Donnadieux INSERM U 223, INSERM U 1 8 8 , FRH, P a r i s , F r a n c e IN VITRO SIMULTANEOUS RELEASE OF ENDOGENOUS SOMATOSTATIN AND GROWTH HORMONE FROM HUMAN ADENOMATOUS PITUITARY CELLS D i s p e r s e d c e l l s o b t a i n e d from 1 0 G H -s e c r e t i n g adenomas w e r e s t u d i e d i n p e r i f u s i o n c o l u m n s , e l u t e d w i t h K r e b s R i n g e r b u f f e r . F r a c t i o n s w e r e c o l l e c t e d e a c h 5 min f o r 5 h o u r s a n d a s s a y e d b y RIA f o r GH a n d SRIF c o nt e n t s . B a s a l GH s e c r e t i o n was v a r i a b l e ( 1 0 t o 94 ng/ml/ l o 6 c e l l s ) . W i t h i n t h e f i r s t 1 5 m i n u t e s o f t h e p e r if u s i o n SRIF was d e t e c t e d i n 5 c a s e s ( 5 t o 4 1 p g / r n l / l~6 c e l l s ) . However i n 5 c a s e s a g r e a t r e l e a s e o f SRIF was o n l y o b s e r v e d a f t e r 90 m i n u t e s o r more (7 t o 25 pq/ml/ --1 0 6 -c e l l s ) . I n 2 c a s e s , d u r i n g t h e p e r i f u s i o n , t h e v ar i a t i o n s o f GH and SRIF l e v e l s w e r e s i g n i f i c a n t l y n e g at i v e l y c o r r e l a t e d ( p ( 0 . 0 0 1 ) . C o n c l u s i o n s : 1 ) SRIF i s r e l e a s e d i n v i t r o from human p i t u i t a r y G H -s e c r e t i n g c e l l s , 2) o r i g i n o f SRIF r e l e a s e : i n t e r n a l i z a t i o n o r s y n t h e s i s ? 3) t h e i n v e r s e c o r r e l a t i o n b e t w e e n SRIF a n d of IR-EGF represent different cleavage products of a common pre-GH l e v e l s s u g g e s t s a r o l e o f t h e i n t r a c e l l u l a r SRIF i n cursor, different tissue specific products, aggregates of EGF, t h e r e g u l a t i o n o f GH s e c r e t i o n . A Maroccan newborn female was admitted to the hospital directly The apparent inability of elevated atrial-natriuretic peptide (ANP) levels to cause natriuresis and diuresis in children with heart failure may be related to a reduced response of target organs to ANP. The cellular effects of ANP seem to be mediated by cGMP a s the second messenger of ANP. Simultaneous measuremen of ANP and cCMP has been shown to be a useful tool to study the cellular response to ANP. Therefore, plasma ANP and cGMP levels were measured by radioimmonoassay in 168 healthy childrer and in 47 children with congenital cardiac diseases. In healthy children ANP and cGMP plasma levels were measured in the range of 5-109 pglml (mean 95.5) and 0.2-2.8 pmollml (mean 1.3) respectively. In children with cardiac diseases significantly higher ANP (range 30-980, mean 280 pglml) and cGMP levels (range 0.2-6.0, mean 2.8 pmollml) were determined. There was a highly significant correlation between the two in children with cardiac diseases (p<0.001). Furthermore, a significant correlation was found between right atrial pressure and ANP levels (p<0.01) suggesting that atrial stretch is a stimulus for ANP release. The positive correlation between ANP and cGMP levels disagrees with the hypothesis that the cellular response to ANP is diminished in children with cardiac diseases.
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W.RascherX, T . T u l a s s a y S , U . H e i n r i c h , R.E. L a n e ( I n t r o d . by U . H e i n r i c h ) D e p a r t m e n t of P e d i a t r i c s , u n i v e r s i t y o f H e i d e l b e r g , Fed. Rep. Germany REGULATION OF PLASMA ATRIAL NATRIURETIC PEPTIDE I N CHILDHOOD a f t e r birth with asphyxia and convulsions. Laboratory examination revealed hypoglycaemia with elevated insul in 1 eve1 s . Glucose infusions in combination with diazoxide treatment could not maintain normoglycaemia. A t 4 weeks of age subtotal pancreatectomy was performed. Pathological examination of the specimen showed nesidioblastosis. A t 8.5 months, a f t e r a period of normoglycaemia, there was a reoccurrence of hypoglycaemia. Frequent feedings, diazoxide o r glucagon treatment failed. A t age 11 months SMS 201-995 was started. The dose was gradually increased from 20 once t o 25 g 8 times per day ( s c administration@ a portable infusion pump,zklomat, Ferring, Kiel). Glucose levels were in the normal range, insulin levels declined. The patient was treated with SMS 201-995 f o r 17 months. After 9 months of treatment the dose could be decreased t o 25 pg 6 times per day sc. Height and weight gain a r e normal. During treatment normal growth hormone levels a r e found during sleep. Psychomotor development i s appropriate f o r age. Short term interruptions of treatment do not e l i c i t a rebound phenomenon with hypoglycaemia, in contrast t o SMS 201-995 withdrawal f o r several hours. In conclusion: the long-acting somatos t a t i n analogue (SMS 201-995) may be an a l t e r n a t i v e therapeutic appraoch in the long term management of hyperinsulinism.
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H6pital des Enfants-Malades INSERM "30, Paris, France and Cell Biology, Uppsala, Sweden*. i n t o t a l r a t pancreatic extracts and i n neonatal r a t i s f e t c e l l s a v e r a g e d 27.8+14.0 fmol$ml (%+sD). N e o n a t e s h a d o n l y i n culture. IGF-I was measured in acidic extract a f t e r gel f i ls l i g h t l y h i g h & mean ANP l e v e T s , w h e r e a s i n p r e m a t u r e t r a t i o n (biogel PIDO). RIA used specific antibody (NIAMDD), purii n f a n t s a t d a y 1 of l i f e ANP was u p t o 1 0 t i m e s h i bound t o t h i s material and the tracer displaced by cold IGF-I 52.0 fmol/ml. ANP c o r r e l a t e d w i t h u r i E e f l o w (~0 . 6 4 , a f t e r 4 hr incubation. IGF-I was also characterized in f e t a l r a t P < 0 . 0 1 ) a n d w i t h sodium e x c r e t i o n ( r : 0 . 6 2 , p,C 0.01 ). c o n c o m i t a n t r e d u c t i o n o f body w e i g h t .
INSULIN-LIKE GROWTH FACTOR I (IGF-I) IN THE RAT PANCREAS AND IN FETAL ISLETS IN CULTURE.

A t r i a l n a t r i u r e t i c p e p t i d e (ANP
In conclusion : IGF-I i s present in the r a t pancreas and in T h e s e o b s e r v a t i o n s s u g g e s t t h a t volume e x p a n s i o n i s a the medium of i s l e t s c e l l s i n culture together with a binding p o t e n t s t i m u l u s o f ANP r e l e a s e i n c h i l d r e n a n d t h a t protein. Effect of GH on IGF-I production in the medium seems t o t h i s hormone i s i m p o r t a n t i n volume h o m e o s t a s i s .
indicate t h a t GH multiplicatory a c t i v i t y on O-cell might be S u p p o r t e d b y D e u t s c h e F o r s c h u n g s g e m e i n s c h a f t Ra 326/1-2 mediated local IGF-I
